Insider Transactions in Q4 2021 at Halozyme Therapeutics, Inc. (HALO)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 08
2021
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
50,000
-4.33%
|
$2,000,000
$40.02 P/Share
|
|
Nov 08
2021
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+7.85%
|
$700,000
$14.66 P/Share
|
|
Nov 05
2021
|
Connie Matsui |
SELL
Open market or private sale
|
Direct |
32,000
-7.77%
|
$1,280,000
$40.45 P/Share
|
|
Oct 12
2021
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,050
+4.88%
|
$104,650
$13.1 P/Share
|
|
Oct 04
2021
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
50,000
-4.3%
|
$2,000,000
$40.46 P/Share
|
|
Oct 04
2021
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+7.85%
|
$700,000
$14.66 P/Share
|
|
Oct 01
2021
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
29,450
-16.52%
|
$1,148,550
$39.93 P/Share
|
|
Oct 01
2021
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
29,450
+14.18%
|
$382,850
$13.1 P/Share
|